DoseVault
Metabolic Compound

Albiglutide

Weekly GLP-1 agonist fused to albumin; discontinued GSK product (Tanzeum/Eperzan).

Scientific Overview

Albiglutide (Tanzeum in US, Eperzan in EU) was a recombinant fusion of two tandem GLP-1 (7-36) molecules with human albumin, developed by GSK and FDA-approved 2014. The HARMONY-OUTCOMES trial showed CV event reduction. GSK voluntarily withdrew the product worldwide in 2018 for commercial reasons despite favorable efficacy.

Key Research Benefits

  • ✓Weekly dosing
  • ✓HbA1c reduction
  • ✓CV benefit (HARMONY)

Potential Side Effects

⚠Injection-site reaction
⚠Diarrhea
⚠Now discontinued

Research Protocols

Common Dosages

Historical

30-50 mg
Weekly SC

“Discontinued 2018”

Note: Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Dose Calculator

🧮 Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

1200 Units

or 12.00 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Explore Albiglutide

Where to source

Vendors with public COAs that stock this category. Affiliate links are disclosed.

  • Limitless Life Nootropics
    FL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • SwissChems
    60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • Amino Club
    EU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.
    COA: Third-partyAffiliate disclosed
    View vendor →

Albiglutide by goal

Read Albiglutide's profile filtered through specific research goals.

Albiglutide for Fat Loss

Molecular Profile

protein
GLP-1 dimer + HSA
645 AA Sequence

Quick Reference

Status
Research Compound
Category
Metabolic
Common Dosage
30-50 mg
Weekly SC

Strictly for research purposes. Not for human consumption.

Related tools

Medical Disclaimer

Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.